Comments on EPA Proposed Rule: Management Standards for Hazardous Waste Pharmaceuticals
Via: Regulations.gov: EPA–HQ–RCRA–2007–0932
Our organizations represent the interests of residents in long-term care facilities and other institutional practice settings, as well as the associated professionals who are committed to caring for the frailest of our citizens. We appreciate the opportunity to comment on the Environmental Protection Agency’s (EPA) proposed rule for handling hazardous waste pharmaceuticals.
The American Society of Consultant Pharmacists (ASCP) is pleased to submit comments on behalf of the undersigned organizations on the EPA’s proposed regulation on management standards for hazardous waste pharmaceuticals.
Summary:
We support efforts to ensure proper handling of hazardous waste pharmaceuticals (HWP) in the long- term care (LTC) setting. Our members are committed to take all reasonable steps to ensure the safety of the LTC residents that we serve and to protect the environment.
Our organizations do have a number of concerns with the proposed rule, such as the inclusion of assisted living facilities (ALF), continuing care retirement communities (CCRC), and nursing facilities (NF) in the definition of LTC facilities, expansion of responsibilities of the pharmacy staff, and its potential impact on the viability of small healthcare entities because of the increased compliance burden.
Recent Posts
-
Experts fear damage to long-term care pharmacies as CMS touts newly negotiated drug prices
Even as the federal government on Thursday touted the billions of dollars in savings seniors can expect to see from newly negotiated, lower drug costs, pharmacies that supply long-term care facilities are warning of dire consequences.
-
Senior Care Pharmacy Coalition & “Save Senior Rx Care” Release Statement on Biden Administration’s Medicare Drug Pricing Announcement
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, and the new Save Senior Rx Care campaign released a statement today in response to the new drug pricing announcement: “Today, the Biden Administration released the negotiated 2026 prices for the ten most expensive Medicare Part D drugs, as […]
-
LTC pharmacies demand ‘sustainable’ payment model ahead of 2026 drug-pricing changes
Many of the nation’s long-term care pharmacies are going to fall below “break-even” and may be forced out of business without additional support when drug-pricing policy changes kick in, sector advocates warned Wednesday.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.